|
RPL8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.11469999897196E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.15089999996876E-06 |
| Normal-vs-Stage2 |
9.53750000000086E-05 |
| Normal-vs-Stage3 |
2.18789999999469E-05 |
| Normal-vs-Stage4 |
8.833700E-04 |
| Stage1-vs-Stage2 |
7.274800E-01 |
| Stage1-vs-Stage3 |
6.943500E-03 |
| Stage1-vs-Stage4 |
5.559000E-03 |
| Stage2-vs-Stage3 |
5.670500E-02 |
| Stage2-vs-Stage4 |
6.684900E-03 |
| Stage3-vs-Stage4 |
1.329650E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.53400003810589E-09 |
| Normal-vs-AfricanAmerican |
2.586900E-04 |
| Normal-vs-Asian |
8.154300E-02 |
| Caucasian-vs-AfricanAmerican |
4.869200E-01 |
| Caucasian-vs-Asian |
4.830000E-01 |
| AfricanAmerican-vs-Asian |
3.360400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.9406999985967E-08 |
| Normal-vs-Female |
1.1188999999856E-06 |
| Male-vs-Female |
4.690400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.25549999999242E-05 |
| Normal-vs-Extreme_Weight |
6.4888999729007E-09 |
| Normal-vs-Obese |
4.13329999999767E-05 |
| Normal-vs-Extreme_Obese |
5.026200E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.092600E-01 |
| Normal_Weight-vs-Obese |
9.232400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.464110E-02 |
| Extreme_Weight-vs-Obese |
4.632000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.628270E-02 |
| Obese-vs-Extreme_Obese |
1.542260E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.035600E-04 |
| Normal-vs-Age(41-60Yrs) |
3.56690000002935E-06 |
| Normal-vs-Age(61-80Yrs) |
1.30240000006943E-07 |
| Normal-vs-Age(81-100Yrs) |
1.040640E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.559900E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.822100E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.578300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.306400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.824000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.297400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62357999999863E-05 |
| Normal-VS-Type2 PRCC |
8.16860000000252E-05 |
| Normal-VS-KIRP CIMP |
1.169470E-04 |
| Normal-VS-Unclassified PRCC |
4.598500E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.033770E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.44679831951089E-11 |
| Type1 PRCC-VS-Unclassified PRCC |
1.676190E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.817400E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
7.474400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.35639999999204E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.68273999999746E-05 |
| Normal-vs-N1 |
4.13989999999975E-05 |
| Normal-vs-N2 |
4.445800E-02 |
| N0-vs-N1 |
2.352200E-02 |
| N0-vs-N2 |
8.102200E-02 |
| N1-vs-N2 |
1.531710E-02 |
|
|
